Compare ASC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASC | NPCE |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.6M | 536.6M |
| IPO Year | 2013 | 2021 |
| Metric | ASC | NPCE |
|---|---|---|
| Price | $15.78 | $16.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $17.00 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 681.6K | 172.6K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | $16.60 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $9.90 | $7.56 |
| 52 Week High | $20.03 | $19.60 |
| Indicator | ASC | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 47.28 | 50.78 |
| Support Level | $14.91 | $15.42 |
| Resistance Level | $15.98 | $17.49 |
| Average True Range (ATR) | 0.77 | 0.91 |
| MACD | 0.13 | -0.03 |
| Stochastic Oscillator | 66.03 | 33.71 |
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.